While the CD4+ fractions of EM T cells were similar, we found a significant increase of CD8+ EM T cells in patients with HL (19.9% ± 11.4 vs 12.2% ± 5.2, p < 0.01) (Fig. 1B). This evidence concerns the gene CD8A and Hodgkins lymphoma.